Atria Wealth Solutions, Inc. Annovis Bio, Inc. Transaction History
Atria Wealth Solutions, Inc.
- $8.74 Billion
- Q4 2024
A detailed history of Atria Wealth Solutions, Inc. transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 13,002 shares of ANVS stock, worth $32,765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,002Holding current value
$32,765% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANVS
# of Institutions
47Shares Held
1.3MCall Options Held
229KPut Options Held
698K-
Vanguard Group Inc Valley Forge, PA466KShares$1.18 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il103KShares$258,7830.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$253,7860.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.6KShares$250,9010.0% of portfolio
-
Merit Financial Group, LLC98.5KShares$248,2600.01% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $20.6M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...